PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta(®)): Pharmacodynamics, Pharmacokinetics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers
PF-06881894，一种拟用于治疗培非格司亭的生物类似药，与美国许可和欧盟批准的培非格司亭参考产品（Neulasta®）相比：在健康志愿者中单次或多次皮下注射的药效学、药代动力学、免疫原性和安全性
期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-020-01387-x
Moosavi, Shahrzad; Borema, Troy; Ewesuedo, Reginald; Harris, Stuart; Levy, Jeffrey; May, Thomas B; Summers, Martin; Thomas, Jeffrey S; Zhang, Jeffrey; Yao, Hsuan-Ming
